NG144 Cannabis-based medicinal products

 In Conditions, NICE guidelines

This NICE guideline was published in November 2019 and covers the prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

It makes five recommendations on:

  • Intractable nausea and vomiting
  • Chronic pain
  • Spasticity
  • Severe treatment-resistant epilepsy
  • Prescribing

For more information, please visit the NICE Guidance page, or the NICE bites document.

Recent Posts

Start typing and press Enter to search